Dr. Fariba Ghodsian is the Chief Investment Officer of DAFNA Capital Management. Dr. Ghodsian completed her postdoctoral fellowship in protein modeling at Harvard Medical School. She received her D. Phil. in Biomedical Engineering from Oxford University in England, M.S. in Chemical Engineering from Massachusetts Institute of Technology, MBA from the University of California at Los Angeles, and B.S. in Chemical Engineering from Technion, Israel Institute of Technology. Prior to joining the firm in 2002, Dr. Ghodsian was Managing Director of Healthcare Research at Roth Capital Partners. Before this, she was a senior biotechnology analyst at Lehman Brothers, Hancock Institutional, and Wedbus